Resources

Resource Center

Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.

In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.

Resources

Filter

No results found

Publications

Filter

The use of monoclonal therapy in the treatment of intraocular inflammatory disease

2000

Nussenblatt, R.B., Fortin, E., Schiffman, R., Risso, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C.K., Waldmann, T.A., Whitcup, S.M.

Timing of retinopathy of prematurity (ROP) events: screening implications

2000

Phelps, D.L., Oden, N.L., Cole, C., Wood, N.E., Young, T.L., Brozanski, B.S.

Untitled

2000

Gonwa, T.A., Johnson, C., Ahsan, N., , , Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., Scotellaro, P., Fitzsimmons, W.

Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP

2000

Cole, C.H., Oden, N.L., Lindblad, A.S., Phelps, D.L., Palmer, E.A.

Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+ cell count in cord blood: The COBLT Experience

2000

Kurtzberg, J., Wagner, E.L., Cairo, M.S., Reese, M., Chun, S., Carter, S.L., Kernan, N.A., Jensen, L., Fraser, J.K.

Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis

2000

Simon, R., Desper, R., Papadimetriou, C., Peng, A., Alberts, D.S., Taetle, R., Trent, J.M., Schäffer, A.A.